Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 6, 2013
Previous Article Next Article

Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

Author affiliations

Abstract

In this study, 22 novel hFTase inhibitors containing 18 scaffolds were identified with IC50 values ranging from 0.0119 to 13.35 μM by structure-based virtual screening, and compounds 2, 7, 9, 10, 14 and 15 showed moderate antiproliferative activity against MCF-7 cells. In particular, compound 2 was the most promising lead compound with nanomolar activity against FTase and antiproliferative activity in the low micromolar range. Possible binding modes of the hit compounds were explored and their structure–activity relationships (SAR) were elucidated by molecular docking simulation. The hit compounds discovered in this work will provide novel scaffolds for further hit-to-lead optimization and lay the foundation for further development of therapeutic candidates for cancer treatments.

Graphical abstract: Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

Back to tab navigation

Supplementary files

Article information


Submitted
21 Feb 2013
Accepted
10 Apr 2013
First published
10 Apr 2013

Med. Chem. Commun., 2013,4, 962-971
Article type
Concise Article

Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

X. Yu, X. Zhao, L. Zhu, C. Zou, X. Liu, Z. Zhao, J. Huang and H. Li, Med. Chem. Commun., 2013, 4, 962
DOI: 10.1039/C3MD00058C

Search articles by author

Spotlight

Advertisements